Adjuvant Epithelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer: Yes, No, Maybe So?
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH. Electronic address: davism6@ccf.org.
Mellar P
MP
Davis
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
Vamsidhar
V
Velcheti
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
Nathan A
NA
Pennell
D000970:Antineoplastic Agents; D002289:Carcinoma, Non-Small-Cell Lung; D066246:ErbB Receptors / Q000235:genetics; D006801:Humans; D008175:Lung Neoplasms; D009154:Mutation; D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases; D017978:Receptors, Growth Factor
D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D017978:Receptors, Growth Factor; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases